URETHANE HYPERGLYCAEMIA AND HYPOTHALAMIC ACTIVATION.
D000315:Adrenalectomy; D001921:Brain / Q000502:physiology*; D002415:Cats; D002698:Chloralose; D003714:Denervation; D003983:Dibenzylchlorethamine; D006145:Guanethidine; D006584:Hexamethonium Compounds; D006591:Hexobarbital; D006943:Hyperglycemia; D007031:Hypothalamus; D007267:Injections; D007274:Injections, Intraperitoneal; D010424:Pentobarbital; D010600:Pharmacology; D011817:Rabbits; D012106:Research; D012110:Reserpine; D013565:Sympatholytics; D014116:Toxicology; D014520:Urethane
D006584:Hexamethonium Compounds; D013565:Sympatholytics; D002698:Chloralose; D014520:Urethane; D003983:Dibenzylchlorethamine; D012110:Reserpine; D006591:Hexobarbital; D010424:Pentobarbital; D006145:Guanethidine
ADRENALECTOMY; BRAIN PHYSIOLOGY; CATS; CHLORALOSE; DENERVATION; DIBENAMINE; EXPERIMENTAL LAB STUDY; GUANETHIDINE; HEXAMETHONIUM COMPOUNDS; HEXOBARBITAL; HYPERGLYCEMIA; HYPOTHALAMUS; INJECTIONS, INTRAPERITONEAL; PENTOBARBITAL; PHARMACOLOGY; RABBITS; RESERPINE; SYMPATHOLYTICS; TOXICOLOGIC REPORT; URETHANE